Design, Synthesis, Biological Evaluation, and Molecular Dynamics of Novel Cholinesterase Inhibitors As Anti-Alzheimer's Agents Publisher Pubmed



Shamsimeymandi R¹ ; Pourshojaei Y^{1, 2} ; Eskandari K¹ ; Mohammadikhanaposhtani M³ ; Abiri A¹ ; Khodadadi A¹ ; Langarizadeh A¹ ; Sharififar F⁴ ; Amirheidari B⁵ ; Akbarzadeh T^{6, 7} ; Lotfian H⁷ ; Foroumadi A^{2, 8} ; Asadipour A¹
Source: Archiv der Pharmazie Published:2019

Abstract

A series of novel chroman-4-one derivatives were designed and synthesized successfully with good to excellent yield (3a–l). In addition, the obtained products were evaluated for their cholinesterase (ChE) inhibitory activities. The results show that among the various synthesized compounds, analogs bearing the piperidinyl ethoxy side chain with 4-hydroxybenzylidene on the 3-positions of chroman-4-one (3l) showed the most potent activity with respect to acetylcholinesterase (anti-AChE activity; IC50 = 1.18 μM). In addition, the structure–activity relationship was studied and the results revealed that the electron-donating groups on the aryl ring of the 3-benzylidene fragment (3k, 3l) resulted in the designed compounds to be more potent ChE inhibitors in comparison with those having electron-withdrawing groups (3h). In this category, the strongest ChE inhibition was found for the compound containing piperidine as cyclic amine, and a hydroxyl group (for AChE, compound 3l) and fluoro group (for butyrylcholinesterase (BuChE, compound 3i) on the para-position of the aryl ring of the benzylidene group. The molecular docking and dynamics studies of the most potent compounds (3i and 3l against BuChE and AChE, respectively) demonstrated remarkable interactions with the binding pockets of the ChE enzymes and confirmed the results obtained through in vitro experiments. © 2019 Deutsche Pharmazeutische Gesellschaft